CVE-2021-1551: medium-severity vulnerability in Cisco Business Wireless Access Point Software
Cisco Small Business 100, 300, and 500 Series Wireless Access Points Command Injection Vulnerabilities
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
13Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 4.7epss 1.7%
Multiple vulnerabilities in the web-based management interface of certain Cisco Small Business 100, 300, and 500 Series Wireless Access Points could allow an authenticated, remote attacker to perform command injection attacks against an affected device. These vulnerabilities are due to improper validation of user-supplied input. An attacker could exploit these vulnerabilities by sending crafted HTTP requests to the web-based management interface of an affected system. A successful exploit could allow the attacker to execute arbitrary commands with root privileges on the device. To exploit these vulnerabilities, the attacker must have valid administrative credentials for the device.
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
Affected products
Cisco · Cisco Business Wireless Access Point SoftwareRelated CVEs — Cisco Business Wireless Access Point Software
In the same product, most dangerous first.
CVE-2021-1401HIGHCisco Small Business 100, 300, and 500 Series Wireless Access Points VulnerabilitiesEPSS 2.0%CVE-2021-1549MEDIUMCisco Small Business 100, 300, and 500 Series Wireless Access Points Command Injection VulnerabilitiesEPSS 1.7%CVE-2021-1555MEDIUMCisco Small Business 100, 300, and 500 Series Wireless Access Points Command Injection VulnerabilitiesEPSS 1.7%CVE-2021-1553MEDIUMCisco Small Business 100, 300, and 500 Series Wireless Access Points Command Injection VulnerabilitiesEPSS 1.7%CVE-2021-1552MEDIUMCisco Small Business 100, 300, and 500 Series Wireless Access Points Command Injection VulnerabilitiesEPSS 1.7%CVE-2021-1550MEDIUMCisco Small Business 100, 300, and 500 Series Wireless Access Points Command Injection VulnerabilitiesEPSS 1.7%